Predible Health is an AI medical tool designed for radiology reporting scenarios. Its main products include Predible Liver and Predible Lung/LungIQ. The website describes it as combining deep learning and cloud computing to run in a standard web browser, providing automated analysis, quantification, and reporting supplementation for liver and lung CT scans.
For the liver, Predible Liver offers automatic segmentation, 3D interactive tools, virtual resection, precise volumetric measurement reporting, liver lesion detection and characterization, and mRECIST-based longitudinal treatment response assessment. It primarily serves liver cancer, liver lesions, and surgical planning scenarios. For the lungs, LungIQ supports lung nodule detection, malignancy scoring, nodule tracking, and treatment response assessment. The website also mentions it can detect nodules as small as 3mm with over 95% sensitivity, while also quantifying COPD emphysema and interstitial lung disease fibrosis subtypes. The algorithms are claimed to be regularly validated through independent clinical studies at partner sites, but more complete research data, sample sizes, or regulatory certifications have not been disclosed.
The website does not disclose prices, plans, or billing methods; it only provides registration portals for Schedule Demo, Try Beta, and early access. Therefore, before purchasing, you need to communicate with the vendor regarding the pilot scope, deployment methods, compliance requirements, and commercial terms.
The pros are that the product focuses on vertical medical scenarios, forming a relatively complete workflow around liver surgical planning, tumor treatment response assessment, and quantitative analysis of lung diseases; cloud and browser access may also lower the barrier to entry. In terms of privacy, the terms state that image transmission uses encrypted connections, data is anonymized before uploading, and users retain ownership of their data. The limitations lie in the lack of public information: there are no details on API or PACS/RIS/EMR integration, no information on Chinese language support, and no clarification on formal clinical applicable regions or certification status. The terms also note that the reliability of Beta/early access services may be lower than that of the official release, and physicians must maintain independent clinical judgment.
It is more suitable for pilot validation by radiology departments, hepatopancreatobiliary and transplant surgery teams, oncology teams, and medical imaging research institutions. Access status from mainland China is unknown; payment methods are also undisclosed. If deployed in China, key considerations include evaluating network connectivity, cross-border medical image data compliance, hospital system integration, and local regulatory requirements. It can be compared with other medical imaging AI solutions like Aidoc, Qure.ai, Lunit, and InferVision.
β This review is compiled from public sources and does not constitute a purchase recommendation. Verify all facts on the vendor's official site. Verify on prediblehealth.com official site.
prediblehealth.com is an India AI Apps provider. TG4G tracks its product information, an overall rating of 6.0/10, and a China-accessibility score of Limited (proxy recommended). Click "Visit Official Site" to reach prediblehealth.com directly.